Comparison of neostigmine and sugammadex for hemodynamic parameters in cardiac patients undergoing noncardiac surgery

This publication has 19 references indexed in Scilit:

• Effects of Sugammadex Doses up to 32 mg/kg Alone or in Combination with Rocuronium or Vecuronium on QTc Prolongation
  Clinical Drug Investigation, 2010
• Reversal of profound vecuronium-induced neuromuscular block under sevoflurane anesthesia: sugammadex versus neostigmine
  BMC Anesthesiology, 2010
• Sugammadex - A short review and clinical recommendations for the cardiac anesthesiologist
  Annals of Cardiac Anaesthesia, 2010
• Sugammadex Provides Faster Reversal of Vecuronium-Induced Neuromuscular Blockade Compared with Neostigmine: A Multicenter, Randomized, Controlled Trial
  Anesthesia & Analgesia, 2010
• Safety and efficacy of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in cardiac patients undergoing noncardiac surgery
  European Journal of Anaesthesiology, 2009
• Reversal of Rocuronium-induced Neuromuscular Blockade with Sugammadex in Pediatric and Adult Surgical Patients
  Anesthesiology, 2009
• Discovery, development, and clinical application of sugammadex sodium, a selective relaxant binding agent
  Drug Design, Development and Therapy, 2008
• Sugammadex Reversal of Rocuronium-Induced Neuromuscular Blockade: A Comparison with Neostigmine???Glycopyrrolate and Edrophonium???Atropine
  Anesthesia & Analgesia, 2007
• Coronary vasospasm during the reversal of neuromuscular block using neostigmine
  Acta Anaesthesiologica Scandinavica, 2005
• Drug-specific cyclodextrins: The future of rapid neuromuscular block reversal
  Drugs of the Future, 2003